| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| SELL | BUY | BUY | BUY | BUY |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 5.39▼ | 5.44▼ | 5.43▼ | 5.11▲ | 4.24▲ |
| MA10 | 5.39▼ | 5.46▼ | 5.28▲ | 4.82▲ | 3.31▲ |
| MA20 | 5.43▼ | 5.28▲ | 5.21▲ | 4.25▲ | 3.67▲ |
| MA50 | 5.46▼ | 5.15▲ | 4.97▲ | 3.16▲ | 4.69▲ |
| MA100 | 5.32▲ | 4.94▲ | 4.55▲ | 3.82▲ | 4.29▲ |
| MA200 | 5.24▲ | 4.49▲ | 3.80▲ | 4.55▲ | 5.35▲ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | -0.005▼ | 0.001▲ | 0.013▲ | 0.073▲ | 0.319▲ |
| RSI | 42.041▼ | 56.009▲ | 60.979▲ | 80.492▲ | 61.073▲ |
| STOCH | 44.329 | 50.319 | 75.433 | 86.202▲ | 88.299▲ |
| WILL %R | -65.217 | -41.085 | -34.416 | -13.384▲ | -7.057▲ |
| CCI | -55.564 | 3.583 | 49.510 | 135.585▲ | 190.115▲ |
|
Thursday, July 17, 2025 04:42 AM
Aldeyra Therapeutics (ALDX) stock in focus as the FDA accepts its resubmitted marketing application for lead drug reproxalap targeting dry eye disease. Read more here.
|
|
Thursday, July 17, 2025 04:00 AM
Aldeyra Therapeutics, Inc. (Nasdaq: ALDX) (Aldeyra) today announced that the U.S. Food and Drug Administration (FDA) has accepted for review the resubmitted New Drug Application (NDA) for topical ...
|
|
Monday, July 07, 2025 04:45 PM
Alexander & Baldwin, Inc. (NYSE: ALEX) ("A&B" or "Company"), a Hawai'i-based owner, operator, and developer of high-quality commercial real estate in Hawai'i, will report results for the second ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 18/07/25 | 5.325 | 5.655 | 5.165 | 5.39 | 1,676,743 |
| 17/07/25 | 5.20 | 5.4093 | 4.88 | 5.03 | 1,928,583 |
| 16/07/25 | 5.00 | 5.18 | 4.9425 | 5.16 | 717,843 |
| 15/07/25 | 5.05 | 5.09 | 4.81 | 4.97 | 1,175,370 |
| 14/07/25 | 4.66 | 5.04 | 4.64 | 5.01 | 1,220,585 |
| 11/07/25 | 4.74 | 4.81 | 4.55 | 4.65 | 1,383,108 |
| 10/07/25 | 4.50 | 4.92 | 4.435 | 4.80 | 1,410,924 |
| 09/07/25 | 4.40 | 4.60 | 4.34 | 4.52 | 1,754,980 |
| 08/07/25 | 4.38 | 4.44 | 4.12 | 4.33 | 1,099,539 |
| 07/07/25 | 4.26 | 4.43 | 4.164 | 4.35 | 906,900 |
|
|
||||
|
|
||||
|
|